Article
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
28 Oct 2021
Abstract excerpt
Treatment options for COVID-19, caused by SARS-CoV-2, remain limited. Understanding viral pathogenesis at the molecular level is critical to develop effective therapy. Some recent studies have explored SARS-CoV-2-host interactomes and provided great resources for understanding viral replication. However, host proteins that functionally associate with SARS-CoV-2 are localized in the corresponding subnetwork within...
Topics
Join the communities discussing this publication.
